Results 131 to 140 of about 12,752 (178)

Chagas disease. [PDF]

CMAJ
Billick MJ, Silverberg SL.
europepmc   +1 more source

Fexinidazole results in specific effects on DNA synthesis and DNA damage in the African trypanosome. [PDF]

PLoS Negl Trop Dis
Berg KE, Rogers I, Ramirez HM, Cornejo J, Durante IM, Hovel-Miner G.   +5 more
europepmc   +1 more source

The impact of probiotic administration on experimental in vitro and in vivo infection by Trypanosoma cruzi. [PDF]

Mem Inst Oswaldo Cruz
Batista DDGJ, Missagia LC, Demarque KC, de Oliveira GM, Batista MM, Soeiro MNC.   +5 more
europepmc   +1 more source

Benznidazole therapy improves pressure overload and cardiac electrical profile in an experimental model of Angiotensin II infusion-induced hypertension: Mechanistic insights. [PDF]

PLoS One
da Silva Pinheiro P, Vilar-Pereira G, Castaño-Barrios L, Peroba Rezende Ramos I, Pedra-Rezende Y, Dantas-Pereira L, Figueiredo Sadok Menna-Barreto R, Gibaldi D, Mata-Santos HA, Lannes-Vieira J.   +9 more
europepmc   +1 more source

Mechanistic Exploration of N,N'-Disubstituted Diamines as Promising Chagas Disease Treatments. [PDF]

Pharmaceuticals (Basel)
Recio-Balsells AI, Reigada C, Mediavilla MG, Panozzo-Zénere E, Villarreal Parra M, Doyle PS, Engel JC, Pereira CA, Cricco JA, Labadie GR.   +9 more
europepmc   +1 more source

Investigation of the effects of benznidazole on the salivary glands: A biochemical, morphological, and functional approach. [PDF]

PLoS One
Lima-da-Silva ECS, Melo WWP, Mendes PFS, Pereira CDS, Matos-Sousa JM, Chagas CKS, Morais HGF, Freitas RA, Chaves-Neto AH, Lima RR.   +9 more
europepmc   +1 more source

New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial. [PDF]

BMJ Open
Marques T, Forsyth C, Barreira F, Lombas C, Blum de Oliveira B, Laserna M, Molina I, Bangher MDC, Javier Fernández R, Lloveras S, Fernández ML, Scapellato P, Patterson P, Garcia W, Ortiz L, Schijman A, Moreira OC, García L, Viele K, Longhi S, Vaillant M, Tipple C, Fraisse L, Silvestre-Sousa A, Sosa-Estani S, Pinazo MJ.   +25 more
europepmc   +1 more source

Antiparasitic Effect of Polyphenols and Terpenes from Natural Products Against <i>Trypanosoma cruzi</i> and <i>Leishmania mexicana</i>. [PDF]

Metabolites
Navarrete-Carriola DV, Rivera G, Ortiz-Pérez E, Paz-González AD, Martínez-Vázquez AV, Aquino-González LV, Argueta-Figueroa L, Doyle MP, Moreno-Rodríguez A.   +8 more
europepmc   +1 more source

Examining Pricing and Availability for Neglected Tropical Disease Therapies in the United States. [PDF]

Open Forum Infect Dis
Goh M, Outterson K, Kesselheim AS.
europepmc   +1 more source

Design, Synthesis, In Vitro and In Silico Biological Evaluation of New Pyridine-2,5-Dicarboxylates Esters Bearing Natural Source Fragments as Anti-Trypanosomatid Agents. [PDF]

Pharmaceutics
Sánchez-Palestino LM, Moreno-Rodríguez A, Navarrete-Carriola DV, Martínez-Archundia M, López-Vargas M, Argueta-Figueroa L, Vázquez-Jiménez LK, Paz-González AD, Ortiz-Pérez E, Doyle MP, Rivera G.   +10 more
europepmc   +1 more source